Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.8921
+0.0620 (7.47%)
At close: Apr 2, 2025, 4:00 PM
0.8791
-0.0130 (-1.46%)
After-hours: Apr 2, 2025, 7:56 PM EDT

Nautilus Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-70.78-63.68-57.92-50.32-15.62
Upgrade
Depreciation & Amortization
6.355.713.422.842.35
Upgrade
Loss (Gain) From Sale of Assets
0.08--0.140.01
Upgrade
Asset Writedown & Restructuring Costs
0.76----
Upgrade
Loss (Gain) From Sale of Investments
-2.8-2.66-0.890.180.28
Upgrade
Stock-Based Compensation
12.712.1410.387.930.37
Upgrade
Change in Accounts Payable
-0.580.39-0.561.260.12
Upgrade
Change in Other Net Operating Assets
-4.88-3.61-0.23-1.28-1.51
Upgrade
Operating Cash Flow
-59.15-51.71-45.81-39.24-14
Upgrade
Capital Expenditures
-2.88-2.44-2.32-2.27-0.92
Upgrade
Investment in Securities
69.13-41.29-23.42-136.7-24.36
Upgrade
Investing Cash Flow
66.25-43.74-25.74-138.96-25.28
Upgrade
Issuance of Common Stock
1.140.370.56335.580.04
Upgrade
Other Financing Activities
----8.13-
Upgrade
Financing Cash Flow
1.140.370.56327.4575.9
Upgrade
Net Cash Flow
8.25-95.08-70.98149.2436.62
Upgrade
Free Cash Flow
-62.03-54.15-48.13-41.51-14.92
Upgrade
Free Cash Flow Per Share
-0.49-0.43-0.39-0.49-0.51
Upgrade
Levered Free Cash Flow
-36.31-32.09-27.58-22.33-7.61
Upgrade
Unlevered Free Cash Flow
-36.31-32.09-27.58-22.33-7.61
Upgrade
Change in Net Working Capital
1.56-0.1-0.71-0.73-0.44
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q